Tuberculosis
Pai, Madhukar, Behr, Marcel A., Dowdy, David, Dheda, Keertan, Divangahi, Maziar, Boehme, Catharina C., Ginsberg, Ann, Swaminathan, Soumya, Spigelman, Melvin, Getahun, Haileyesus, Menzies, Dick, Raviglione, Mario·2016·Nature Reviews Disease Primers
Cited by (1,000)
Items 101–200 of 1,000
- Tuberculosis Diagnosis: Current, Ongoing, and Future ApproachesGuilherme Bartolomeu-Gonçalves, Joyce Marinho de Souza, Bruna Terci Fernandes, Laís Fernanda de Almeida Spoladori, Guilherme Ferreira Correia, Isabela Madeira de Castro, Paulo Henrique Guilherme Borges, Gislaine Silva-Rodrigues, Eliandro Reis Tavares, Lucy Megumi Yamauchi et al. · 2024 · Diseases
- Microparticles prepared with 50–190 kDa chitosan as promising non-toxic carriers for pulmonary delivery of isoniazidPaula Martins de Oliveira, Breno N. Matos, Priscilla Aparecida Tártari Pereira, Taís Gratieri, Lúcia Helena Faccioli, Marcílio Cunha‐Filho, Guilherme M. Gelfuso · 2017 · Carbohydrate Polymers
- Label-Free and Real-Time Detection of Tuberculosis in Human Urine Samples Using a Nanophotonic Point-of-Care PlatformPatricia Ramirez‐Priego, Daan Martens, Ayssar A. Elamin, Pieterjan Soetaert, W. Van Roy, Rita Vos, Birgit Anton, Ronny Bockstaele, Holger Becker, Mahavir Singh et al. · 2018 · ACS Sensors
- Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infectionGemma O’Connor, Nitya Krishnan, Aidan Fagan-Murphy, Joseph P. Cassidy, Seónadh M. O’Leary, Brian D. Robertson, Joseph Keane, Mary P. O’Sullivan, Sally‐Ann Cryan · 2018 · European Journal of Pharmaceutics and Biopharmaceutics
- Classical CD4 T cells as the cornerstone of antimycobacterial immunityJeffrey Morgan, Kaylin Muskat, Rashmi Tippalagama, Alessandro Sette, Julie G. Burel, Cecilia S. Lindestam Arlehamn · 2021 · Immunological Reviews
- Tuberculosis and risk of cancer: A systematic review and meta-analysisPauline Luczynski, Philip Poulin, Kamila Romanowski, James Cameron Johnston · 2022 · PLoS ONE
- Virulence Factors of Mycobacterium tuberculosis as Modulators of Cell Death MechanismsLucero A. Ramón‐Luing, Yadira Palacios, Andy Ruíz, Norma Angélica Téllez-Navarrete, Leslie Chávez‐Galán · 2023 · Pathogens
- Genome wide approaches discover novel Mycobacterium tuberculosis antigens as correlates of infection, disease, immunity and targets for vaccinationMariateresa Coppola, Tom H. M. Ottenhoff · 2018 · Seminars in Immunology
- Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosisNathella Pavan Kumar, Kadar Moideen, Arul Nancy, Vijay Viswanathan, Basavaradhya S. Shruthi, Shanmugam Sivakumar, Mohan Natarajan, Hardy Kornfeld, Subash Babu · 2019 · Scientific Reports
- Latent Tuberculosis: Two Centuries of Confusion.Marcel A. Behr, Eva Kaufmann, Jacalyn M. Duffin, Paul H. Edelstein, Lalita Ramakrishnan · 2021 · Apollo (University of Cambridge)
- Interaction of Mycobacteria With Host Cell InflammasomesShivangi Rastogi, Volker Briken · 2022 · Frontiers in Immunology
- mRNA vaccines: a new opportunity for malaria, tuberculosis and HIVLaura Matarazzo, Paulo J. G. Bettencourt · 2023 · Frontiers in Immunology
- Targeting DNA Replication and Repair for the Development of Novel Therapeutics against TuberculosisMichael Reiche, Digby Francis Warner, Valerie Mizrahi · 2017 · Frontiers in Molecular Biosciences
- Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticalsRydvikha Govender, Susanna Abrahmsén‐Alami, Anette Larsson, Staffan Folestad · 2020 · European Journal of Pharmaceutics and Biopharmaceutics
- In-host population dynamics of Mycobacterium tuberculosis complex during active diseaseRoger Vargas, Luca Freschi, Maximillian G. Marin, L. Elaine Epperson, Melissa Laird Smith, Irina A. Oussenko, David Durbin, Michael Strong, Max Salfinger, Maha Reda Farhat · 2021 · eLife
- The emerging role of exosomal miRNAs as a diagnostic and therapeutic biomarker in Mycobacterium tuberculosis infectionRasoul Mirzaei, Sajad Babakhani, Parisa Ajorloo, Razieh Heidari Ahmadi, Seyed Reza Hosseini‐Fard, Hossein Keyvani, Yaghoub Ahmadyousefi, Ali Teimoori, Farhad Zamani, Sajad Karampoor et al. · 2021 · Molecular Medicine
- Microbiota and Tuberculosis: A Potential Role of Probiotics, and PostbioticsYue Liu, Jiaqi Wang, Changxin Wu · 2021 · Frontiers in Nutrition
- A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active TuberculosisVera Marie Kroesen, Paula Rodríguez‐Martínez, Eric García, Yaiza Rosales, Jorge Dı́az, Montse Martín-Céspedes, Gustavo Tapia, Maria‐Rosa Sarrias, Père-Joan Cardona, Cristina Vilaplana · 2018 · Frontiers in Immunology
- The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic MechanismsGregory W. Wigger, Tara C. Bouton, Karen Rita Jacobson, Sara C. Auld, Samantha M. Yeligar, Bashar S. Staitieh · 2022 · Frontiers in Immunology
- T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translationMunyaradzi Musvosvi, Darragh Duffy, Elizabeth Filander, Hadn Africa, Simbarashe Mabwe, Lungisa Jaxa, Nicole Bilek, Alba Llibre, Vincent Rouilly, Mark Hatherill et al. · 2018 · European Respiratory Journal
- Systematic Review and Meta-Analysis of Sex Differences in Social Contact Patterns and Implications for Tuberculosis Transmission and ControlKatherine Chisholm Horton, Anne L. Hoey, Guillaume Béraud, Elizabeth Lucy Corbett, Richard Guy White · 2020 · Emerging infectious diseases
- Evolution of tuberculosis diagnostics: From molecular strategies to nanodiagnosticsSrestha Mukherjee, Summaya Perveen, Anjali Negi, Rashmi Sharma · 2023 · Tuberculosis
- Mycobacterium tuberculosis MetabolismGabriel T. Mashabela, Timothy J. de Wet, Digby Francis Warner · 2019 · Microbiology Spectrum
- Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosisPhuong Chi Nguyen, Vincent Delorme, Anaïs Bénarouche, Benjamin P. Martin, Rishi R. Paudel, Giri Raj Gnawali, Abdeldjalil Madani, Rémy Puppo, Valérie Landry, Laurent Kremer et al. · 2017 · Scientific Reports
- Tuberculosis in ChildrenPeter J. Holmberg, Zelalem Temesgen, Ritu Banerjee · 2019 · Pediatrics in Review
- Pyroptosis in host defence against bacterial infectionDominik Brokatzky, Serge Mostowy · 2022 · Disease Models & Mechanisms
- Targeting isocitrate lyase for the treatment of latent tuberculosisRam Prasad Bhusal, Ghader Bashiri, Brooke X. C. Kwai, Jonathan Sperry, Ivanhoe K. H. Leung · 2017 · Drug Discovery Today
- Spatio-temporal variation in tuberculosis incidence and risk factors for the disease in a region of unbalanced socio-economic developmentLi Wang, Chengdong Xu, Maogui Hu, Jiajun Qiao, Wei Chen, Tao Li, Songbo Qian, Mingtao Yan · 2021 · BMC Public Health
- Tuberculosis pathophysiology and anti-VEGF interventionDavid P. Maison · 2022 · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
- Tuberculosis caused by Mycobacterium africanum: Knowns and unknownsMarta Silva, Baltazar Cá, Nuno Sampaio Osório, Pedro Rodrigues, Ana Raquel Maceiras, Margarida Saraiva · 2022 · PLoS Pathogens
- Treatment of Isoniazid-Resistant Pulmonary TuberculosisByung Woo Jhun, Won‐Jung Koh · 2019 · Tuberculosis & respiratory diseases
- The Human Microbiota, Infectious Disease, and Global Health: Challenges and OpportunitiesAbraham J. Waldman, Emily P. Balskus · 2017 · ACS Infectious Diseases
- High dose dry powder inhalers to overcome the challenges of tuberculosis treatmentMohammad A. M. Momin, Ian G. Tucker, Shyamal C. Das · 2018 · International Journal of Pharmaceutics
- Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort studyCaian L. Vinhaes, Deivide Oliveira-de-Souza, Paulo S. Silveira-Mattos, Betânia M. F. Nogueira, Ruiru Shi, Wang Wei, Xing Yuan, Guolong Zhang, Ying Cai, Clifton E. Barry et al. · 2019 · Cytokine
- Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agentsAna Flávia Borsoi, Josiane Delgado Paz, Bruno Lopes Abbadi, Fernanda Souza Macchi, Nathalia Denise de Moura Sperotto, Kenia Pissinate, Raoní Scheibler Rambo, Alessandro Silva Ramos, Diana Machado, Miguel Viveiros et al. · 2020 · European Journal of Medicinal Chemistry
- Glyphosate: Hepatotoxicity, Nephrotoxicity, Hemotoxicity, Carcinogenicity, and Clinical Cases of Endocrine, Reproductive, Cardiovascular, and Pulmonary System IntoxicationJarosław Mazuryk, Katarzyna Klepacka, Wlodzinierz Kutner, P. Sharma · 2024 · ACS Pharmacology & Translational Science
- Detection of tuberculosis in patients with the use of portable SPR deviceMaciej Trzaskowski, Agnieszka Napiórkowska, EWA M. AUGUSTYNOWICZ-KOPEĆ, Tomasz Ciach · 2018 · Sensors and Actuators B Chemical
- Beyond Killing Mycobacterium tuberculosis: Disease ToleranceMaziar Divangahi, Nargis Khan, Eva Kaufmann · 2018 · Frontiers in Immunology
- The Emerging Role of Myeloid-Derived Suppressor Cells in TuberculosisTandeka Magcwebeba, Anca Dorhoi, Nelita du Plessis · 2019 · Frontiers in Immunology
- Diagnostic Accuracy of a Novel and Rapid Lipoarabinomannan Test for Diagnosing Tuberculosis Among People With Human Immunodeficiency VirusStephanie Bjerrum, Tobias Broger, Rita Székely, Satoshi Mitarai, Japheth A. Opintan, Ernest Kenu, Margaret Yaa Lartey, Kennedy Kwasi Addo, Kinuyo Chikamatsu, Aurélien Macé et al. · 2019 · Open Forum Infectious Diseases
- ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel DiseaseRoger M. Feakins, Joana Torres, Paula Borralho, Johan M. Burisch, Tiago Cúrdia Gonçalves, Lissy de Ridder, Ann L. C. Driessen, Triana Lobatón, Luis A. Menchen, Aart Mookhoek et al. · 2021 · Journal of Crohn s and Colitis
- Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?Lehlogonolo N. F. Maphalle, Bozena B. Michniak‐Kohn, Modupe Olufunmilayo Ogunrombi, Oluwatoyin A. Adeleke · 2022 · Children
- Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid CocrystalBattini Swapna, M. K. Chaitanya Mannava, Ashwini Kumar Nangia · 2018 · Journal of Pharmaceutical Sciences
- Potential Diagnostic Properties of Chest Ultrasound in Thoracic Tuberculosis—A Systematic ReviewFrancesco Di Gennaro, Luigi Pisani, Nicola Veronese, Damiano Pizzol, Valeria Lippolis, Annalisa Saracino, Laura Monno, Michaëla A. M. Huson, Roberto Copetti, Giovanni Putoto et al. · 2018 · International Journal of Environmental Research and Public Health
- Pyrazinamide drug resistance in RpsA mutant (∆438A) of Mycobacterium tuberculosis : Dynamics of essential motions and free‐energy landscape analysisAditi Puri Singh, Pallavi Somvanshi, Abhinav Grover · 2018 · Journal of Cellular Biochemistry
- How Well Do Routine Molecular Diagnostics Detect Rifampin Heteroresistance in Mycobacterium tuberculosis?Kamela Charmaine S. Ng, Philip Supply, Frank G. J. Cobelens, Cyril Gaudin, Julian González-Martín, Bouke Catherine de Jong, Leen Rigouts · 2019 · Journal of Clinical Microbiology
- Vaccine Development Against Tuberculosis Over the Last 140 Years: Failure as Part of SuccessStefan H. E. Kaufmann · 2021 · Frontiers in Microbiology
- Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic reviewJacob Bigio, Mikashmi Kohli, Joel Shyam Klinton, Emily Lai-Ho MacLean, Genevieve C. Gore, Peter M. Small, Morten Rühwald, Stefan Fabian Weber, Saurabh Kumar Jha, Madhukar Pai · 2021 · PLoS ONE
- Host-directed therapies in pulmonary tuberculosis: Updates on anti-inflammatory drugsJuan Manuel Cubillos-Angulo, Betânia M. F. Nogueira, María B. Arriaga, Beatriz Barreto‐Duarte, Mariana Araújo‐Pereira, Catarina Dinis Fernandes, Caian L. Vinhaes, Klauss Villalva-Serra, Vanessa M. Nunes, João Pedro Miguez-Pinto et al. · 2022 · Frontiers in Medicine
- Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis : Computational Analysis of Physicochemical and ADMET PropertiesPatrícia S. M. Amado, Christopher M. Woodley, Maria L. S. Cristiano, Paul M. O’Neill · 2022 · ACS Omega
- Tuberculosis innovations mean little if they cannot save livesMadhukar Pai, Jennifer Joan Furin · 2017 · eLife
- Advances in Drug Discovery of New Antitubercular Multidrug-Resistant CompoundsGuilherme Fernandes, Chung Man Chin, Jean Leandro dos Santos · 2017 · Pharmaceuticals
- Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort studyArto Yuwono Soeroto, Bony Wiem Lestari, Prayudi Santoso, Lidya Chaidir, Basti Andriyoko, Bachti Alisjahbana, Reinout van Crevel, Philip C. Hill · 2019 · PLoS ONE
- MiR‐21‐5p regulates mycobacterial survival and inflammatory responses by targeting Bcl‐2 and TLR4 in Mycobacterium tuberculosis‐infected macrophagesZhonghua Zhao, Jinzhu Hao, Xia Li, Yanfang Chen, Xiaoyan Qi · 2019 · FEBS Letters
- Detection and Quantification of HspX Antigen in Sputum Samples Using Plasmonic Biosensing: Toward a Real Point-of-Care (POC) for Tuberculosis DiagnosisE. Cristina Peláez-Gutierrez, M.‐Carmen Estévez, Alvaro Monguí, M-Carmen Menéndez, Carlos Toro, Oscar Herrera, Jaime Robledo, Maria J. García, Patricia Del Portillo, Laura M. Lechuga · 2020 · ACS Infectious Diseases
- Systemic Inflammation Associated with Immune Reconstitution Inflammatory Syndrome in Persons Living with HIVCaian L. Vinhaes, Mariana Araújo‐Pereira, Rafael Tibúrcio, Juan Manuel Cubillos-Angulo, Fernanda O. Demitto, Kevan Akrami, Bruno B. Andrade · 2021 · Life
- Diagnostic Accuracy of the Artificial Intelligence Methods in Medical Imaging for Pulmonary Tuberculosis: A Systematic Review and Meta-AnalysisYuejuan Zhan, Yuqi Wang, Wendi Zhang, Binwu Ying, Chengdi Wang · 2022 · Journal of Clinical Medicine
- Tuberculosis—a World Health Organization PerspectiveGiovanni Sotgiu, Giorgia Sulis, Alberto Matteelli · 2017 · Microbiology Spectrum
- Genetic Resistance to Mycobacterium tuberculosis Infection and DiseaseMarlo Möller, Craig John Kinnear, Marianna Orlova, Elouise E. Kroon, Paul D. van Helden, Erwin Schurr, Eileen Garner Hoal · 2018 · Frontiers in Immunology
- Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed TherapiesPobitra Borah, Pran Kishore Deb, Katharigatta Narayanaswamy Venugopala, Nizar A. Al‐Shar’i, Vinayak Singh, Satyendra Deka, Amavya Srivastava, Vinod K. Tiwari, Raghu Prasad Mailavaram · 2020 · Current Topics in Medicinal Chemistry
- Differential Recognition of Mycobacterium tuberculosis –Specific Epitopes as a Function of Tuberculosis Disease HistoryThomas J. Scriba, Chelsea Carpenter, Sebastian Carrasco Pro, John Sidney, Munyaradzi Musvosvi, Virginie Rozot, Grégory Seumois, Sandy Lisette Rosales, Pandurangan Vijayanand, Delia Goletti et al. · 2017 · American Journal of Respiratory and Critical Care Medicine
- New antituberculous drugs derived from natural products: current perspectives and issues in antituberculous drug developmentMasayuki Igarashi, Yoshimasa Ishizaki, Yoshiaki Takahashi · 2017 · The Journal of Antibiotics
- A Bayesian Approach to Understanding Sex Differences in Tuberculosis Disease BurdenKatherine Chisholm Horton, Tom Sumner, Rein M G J Houben, Elizabeth Lucy Corbett, Richard Guy White · 2018 · American Journal of Epidemiology
- Structural Prediction and Mutational Analysis of Rv3906c Gene of Mycobacterium tuberculosis H37Rv to Determine Its Essentiality in SurvivalMd Amjad Beg, Shivangi Shivangi, Sonu Chand Thakur, Laxman S. Meena · 2018 · Advances in Bioinformatics
- Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised PatientsMi Ra Ryu, Min‐Seung Park, Eun Hye Cho, Chul Won Jung, Kihyun Kım, Seok Jin Kim, Ha Young Oh, Wooseong Huh, Hye Ryoun Jang, Won‐Jung Koh et al. · 2018 · Journal of Clinical Microbiology
- Reprogramming of Small Noncoding RNA Populations in Peripheral Blood Reveals Host Biomarkers for Latent and Active Mycobacterium tuberculosis InfectionLeonardo Silva de Araujo, Marcelo Ribeiro Alves, Thyago Leal-Calvo, Janaína Leung, Verónica Durán, Mohamed Samir, Steven Roger Talbot, Aravind Tallam, Fernanda Carvalho de Queiroz Mello, Robert Geffers et al. · 2019 · mBio
- Advances in the design of combination therapies for the treatment of tuberculosisJonah Larkins‐Ford, Bree B. Aldridge · 2022 · Expert Opinion on Drug Discovery
- Autophagy promotes efficient T cell responses to restrict high-dose Mycobacterium tuberculosis infection in miceSiwei Feng, Michael E. McNehlan, Rachel L. Kinsella, Chanchal Sur Chowdhury, Sthefany M. Chavez, Sumanta Kumar Naik, Samuel R. McKee, Jacob A. Van Winkle, Neha Dubey, Amanda N. Samuels et al. · 2024 · Nature Microbiology
- Horizontal acquisition of a hypoxia-responsive molybdenum cofactor biosynthesis pathway contributed to Mycobacterium tuberculosis pathoadaptationFlorence Levillain, Yannick Poquet, Ludovic Mallet, Serge Mazères, Michaël Marceau, Roland Brosch, Franz‐Christoph Bange, Philip Supply, Axel Magalon, Olivier Neyrolles · 2017 · PLoS Pathogens
- Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of TuberculosisJulie G. Burel, Mariana Babor, Mikhail Pomaznoy, Cecilia S. Lindestam Arlehamn, Nabeela A. Khan, Alessandro Sette, Bjoern Peters · 2019 · Frontiers in Immunology
- Comparative genomics of Mycobacterium africanum Lineage 5 and Lineage 6 from Ghana suggests distinct ecological nichesI. Otchere, Mireia Coscollá, L. Sánchez-Busó, A. Asante-Poku, D. Brites, C. Loiseau, C. Meehan, S. Osei-Wusu, A. Forson, Clement Laryea et al. · 2018 · Scientific Reports
- Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potentialIrene Pérez, Santiago Uranga, Fadel Sayes, Wafa Frigui, Sofía Samper, Ainhoa Arbués, Nacho Aguiló, Roland Brosch, Carlos Martı́n, Jesús Gonzalo‐Asensio · 2020 · EBioMedicine
- Aerosol pulmonary immune engineeringEmma R. Sudduth, Michael Trautmann-Rodriguez, Nicole A. Gill, Kartik Bomb, Catherine A. Fromen · 2023 · Advanced Drug Delivery Reviews
- Bacteriophage therapy for the treatment of Mycobacterium tuberculosis infections in humanized miceFan Yang, Alireza Labani‐Motlagh, José Alejandro Bohórquez, Jôsimar Dornelas Moreira, Danish Ansari, Sahil Patel, Fabrizio Spagnolo, Jon Florence, Abhinav Vankayalapati, Tsuyoshi Sakai et al. · 2024 · Communications Biology
- Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristicsAlvin Kuo Jing Teo, Emily Lai-Ho MacLean, Greg James Fox · 2024 · European Respiratory Review
- Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet?Robyn S. Lee, Madhukar Pai · 2017 · Journal of Clinical Microbiology
- Polyester as Antigen Carrier toward Particulate VaccinesMajela González-Miró, Shuxiong Chen, Zennia Jean Gonzaga, Benjamin J. Evert, David Wibowo, Bernd H. A. Rehm · 2019 · Biomacromolecules
- An RNA-seq Based Machine Learning Approach Identifies Latent Tuberculosis Patients With an Active Tuberculosis ProfileOlivia Estévez, Luis Anibarro, Elina Garet, Ángeles Pallarés, Laura Barcia, Laura Calviño, Cremildo Maueia, Tufária Mussá, Florentino Fdez‐Riverola, Daniel Glez‐Peña et al. · 2020 · Frontiers in Immunology
- Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise ReviewGabriel S. Oliveira, Raquel P. Costa, Paula A. C. Gomes, Maria Salomé Gomes, Tânia Silva, Cátia A. S. Teixeira · 2021 · Pharmaceuticals
- Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohortKristina L. Bajema, Ingrid Valerie Bassett, Sharon M. Coleman, Douglas Ross, Kenneth A. Freedberg, Anna Wald, Paul K. Drain · 2019 · BMC Infectious Diseases
- Immunologic, metabolic and genetic impact of diabetes on tuberculosis susceptibilityPhillip Ssekamatte, Obondo James Sande, Reinout van Crevel, Irene Andia Biraro · 2023 · Frontiers in Immunology
- Plant antibacterials: The challenges and opportunitiesTomayo I. Berida, Yemi Adekola Adekunle, Hannah Odunola Dada-Adegbola, Ayoub Kdimy, Sudeshna Roy, Satyajit Dey Sarker · 2024 · Heliyon
- Unsupervised CT Lung Image Segmentation of a Mycobacterium Tuberculosis Infection ModelPedro M. Gordaliza, Arrate Muñoz‐Barrutia, Mónica Abella, Manuel Desco, Sally A. Sharpe, Juan José Vaquero · 2018 · Scientific Reports
- The role of super-spreading events in Mycobacterium tuberculosis transmission: evidence from contact tracingYayehirad Alemu Melsew, Manoj Gambhir, Allen C. Cheng, Emma Sue McBryde, Justin Timothy Denholm, Ee Laine Tay, James McCracken Trauer · 2019 · BMC Infectious Diseases
- Tracking down the White Plague: The skeletal evidence of tuberculous meningitis in the Robert J. Terry Anatomical Skeletal CollectionOlga Spekker, David R. Hunt, László Paja, Erika Molnár, György Pálfi, Michael Schultz · 2020 · PLoS ONE
- Natural-Product-Based Solutions for Tropical Infectious DiseasesOyelola Adegboye, Matthew A. Field, Andreas Kupz, Saparna Pai, Dileep Sharma, Michael J. Smout, Phurpa Wangchuk, Yide Wong, Claire Loiseau · 2021 · Clinical Microbiology Reviews
- Antitubercular Bis-Substituted Cyclam Derivatives: Structure–Activity Relationships and in Vivo StudiesMalcolm P. Spain, Joseph K.-H. Wong, Gayathri Nagalingam, James M. Batten, Elinor Hortle, Stefan H. Oehlers, Xiao Fan Jiang, Hasini E. Murage, Jack T. Orford, Patrick Crisologo et al. · 2018 · Journal of Medicinal Chemistry
- Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in childrenMichela Sali, Danilo Buonsenso, Pamela D’Alfonso, Flavio De Maio, Manuela Ceccarelli, Basem Battah, Ivana Palucci, Teresa Chiacchio, Delia Goletti, Maurizio Sanguinetti et al. · 2018 · Journal of Infection
- Characterisation of genes differentially expressed in macrophages by virulent and attenuated Mycobacterium tuberculosis through RNA-Seq analysisJunghwan Lee, Sung‐Gwon Lee, Kee Kwang Kim, Yun-Ji Lim, Ji-Ae Choi, Soo‐Na Cho, Chungoo Park, Chang‐Hwa Song · 2019 · Scientific Reports
- Cross-validation of existing signatures and derivation of a novel 29-gene transcriptomic signature predictive of progression to TB in a Brazilian cohort of household contacts of pulmonary TBSamantha Leong, Yue Zhao, Rodrigo Ribeiro‐Rodrigues, Edward C. Jones‐López, Carlos Acuña-Villaorduña, Patrícia Marques Rodrigues, Moisés Palaci, David Alland, Reynaldo Dietze, Jerrold J. Ellner et al. · 2020 · Tuberculosis
- Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoringRim Bayaa, Mame Diarra Ndiaye, Carole Chedid, Eka Kokhreidze, Nestani Tukvadze, Sayera Banu, Mohammad Khaja Mafij Uddin, Samanta Biswas, Rumana Nasrin, Paulo PR. Ranaivomanana et al. · 2021 · Scientific Reports
- Neutrophils Contribute to Severity of Tuberculosis Pathology and Recovery From Lung Damage Pre- and PosttreatmentCaleb Nwongbouwoh Muefong, Olumuyiwa Owolabi, Simon A. Donkor, Salome Charalambous, Abhishek Bakuli, Andrea Rachow, Christof Geldmacher, Jayne S. Sutherland · 2021 · Clinical Infectious Diseases
- Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trialPaulo César Pereira dos Santos, Nicole L. Messina, Roberto Dias de Oliveira, Patrícia Vieira da Silva, Marco Antonio Moreira Puga, Margareth Pretti Dalcolmo, Glauce dos Santos, Marcus Lacerda, Bruno Araújo Jardim, Fernando Fonseca de Almeida e Val et al. · 2024 · The Lancet Infectious Diseases
- Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen DerivativesChristopher M. Goins, Steven Dajnowicz, Sandeep Thanna, Steven J. Sucheck, Jerry M. Parks, Donald R. Ronning · 2017 · ACS Infectious Diseases
- Pathogenesis and Animal Models of Post-Primary (Bronchogenic) Tuberculosis, A ReviewRobert Lee Hunter, Jeffrey K. Actor, Shen‐An Hwang, Arshad Khan, Michael E. Urbanowski, Deepak Kaushal, Chinnaswamy Jagannath · 2018 · Pathogens
- How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriersLena Faust, Morten Rühwald, Samuel G. Schumacher, Madhukar Pai · 2020 · Health Science Reports
- Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in miceCameron C. Hanna, Anneliese S. Ashhurst, Diana H. Quan, Joshua W. C. Maxwell, Warwick J. Britton, Richard J. Payne · 2021 · Proceedings of the National Academy of Sciences
- Genitourinary Tuberculosis: A Comprehensive Review of a Neglected Manifestation in Low-Endemic CountriesGuglielmo Mantica, Francesca Ambrosini, Niccolò Riccardi, Enrico Vecchio, Lorenzo Rigatti, Aldo Franco De Rose, André van der Merwe, Carlo Terrone, Riccardo Bartoletti, Gernot Bonkat · 2021 · Antibiotics
- Modifications, biological origin and antibacterial activity of naphthalenoid ansamycinsNatalia Skrzypczak, Piotr Przybylski · 2022 · Natural Product Reports
- Epidemiology of tuberculous lymphadenitis in Africa: A systematic review and meta-analysisDaniel Shitu Mekonnen, Awoke Derbie, Andargachew Abeje, Abebe Shumet, Endalkachew Nibret, Fantahun Biadglegne, Abaineh Munshae, Kidist Bobosha, Liya Wassie, Stefan Berg et al. · 2019 · PLoS ONE